Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
12/09/1998 | EP0422186B1 Use of oncostatin m for suppressing mhc antigens |
12/09/1998 | EP0332667B2 Vector for integration site independent gene expression in mammalian host cells |
12/09/1998 | CN1201489A Alkaline protease, process for production thereof, using method thereof and microorganism producing same |
12/09/1998 | CN1201465A New DNA molecules |
12/08/1998 | US5847097 Methods of generating desired amino-terminal residues in peptides |
12/08/1998 | US5847093 Human apoptosis regulator |
12/08/1998 | US5847082 Terminal complement inhibitor fusion proteins |
12/08/1998 | US5847078 Polypeptide capable of differentiating and maturing malignant cells into normal cells or capable of accelerating the formulation of erythroblasts |
12/08/1998 | US5847077 Fungal multisubunit protein complex critical for expression of fungal proteins |
12/08/1998 | US5846949 Method for eliciting an immune response using a gene expression system that co-delivers an RNA polymerase with DNA |
12/08/1998 | US5846948 Herpes simplex virus ORF P is a repressor of viral protein synthesis |
12/08/1998 | US5846947 Composition containing nucleic acids, preparation and uses |
12/08/1998 | US5846935 Modified ciliary neurotrophic factors |
12/08/1998 | US5846929 Purification of type G botulinum neurotoxin and pharmaceutical compositions thereof |
12/08/1998 | US5846819 Recombinant expression vectors for expression of heterologous proteins |
12/08/1998 | US5846800 Nucleic acid molecules encoding a novel receptor-type protein tyrosine phosphatase-σ |
12/08/1998 | US5846795 RNA transformation vector |
12/08/1998 | US5846782 Targeting adenovirus with use of constrained peptide motifs |
12/08/1998 | US5846779 Nucleic acids encoding murine UCP3 genes |
12/08/1998 | US5846772 Two component signal transduction system response regulator polynucleotides of Staphylococcus aureus |
12/08/1998 | US5846767 Expression of self processing polyproteins in transgenic plants |
12/08/1998 | US5846766 Oxytocin receptor and DNA coding therefor |
12/08/1998 | US5846764 Materials and methods relating to proteins that interact with casein kinase I |
12/08/1998 | US5846751 Test kits and methods for detecting H. pylori |
12/08/1998 | US5846740 Methods and kits useful for detecting autoantibody to glutamic acid decarboxylase |
12/08/1998 | US5846733 Structural phosphoprotein (PP150) of human cytomegalovirus, and the preparation and use thereof |
12/08/1998 | US5846732 Peptides of caseinomacropeptide, antibodies against the said peptides, and uses |
12/08/1998 | US5846725 Methods for identifying cisplatin resistant tumor cells |
12/08/1998 | US5846714 Method of identifying a chemical that alters dissociation of an NF-KB/IKB complex |
12/08/1998 | US5846712 Tumor suppressor gene, HIC-1 |
12/08/1998 | US5846711 Nuclear hormone receptor-interacting polypeptides and related molecules and methods |
12/08/1998 | US5846707 Herpes simplex virus as a vector |
12/08/1998 | US5846540 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
12/08/1998 | US5846538 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
12/08/1998 | US5846536 Restoration of normal phenotype in cancer cells |
12/08/1998 | US5846533 Antibodies specific for native PrPSc |
12/08/1998 | US5846528 Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence |
12/08/1998 | US5846527 Continuous cell line and vaccine against avian coccidia |
12/08/1998 | CA2066612C Method of producing fusion proteins |
12/08/1998 | CA2056086C Cloned gene encoding for bacteriocin from pediococcus acidilactici |
12/08/1998 | CA2055598C Feline calicivirus gene |
12/08/1998 | CA1340173C Production and purification of a protein fused to a binding protein |
12/04/1998 | CA2233587A1 Novel compounds |
12/03/1998 | WO1998054353A1 Methods of making an rnp particle having nucleotide integrase activity |
12/03/1998 | WO1998054347A1 Integrin-targeting vectors having transfection activity |
12/03/1998 | WO1998054346A1 Alternatively targeted adenovirus |
12/03/1998 | WO1998054339A1 PROCESS FOR PREPARING RECOMBINANT PROTEINS USING HIGHLY EFFICIENT EXPRESSION VECTOR FROM $i(SACCHAROMYCES CEREVISIAE) |
12/03/1998 | WO1998054336A1 Method for mass production of antimicrobial peptide |
12/03/1998 | WO1998054324A1 Human multiple endocrine neoplasia type 1 protein |
12/03/1998 | WO1998054322A1 Osf2/cbfa1 compositions and methods of use |
12/03/1998 | WO1998054321A1 New human dp1 homolog |
12/03/1998 | WO1998054318A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33 |
12/03/1998 | WO1998054316A1 Sodium channel receptor |
12/03/1998 | WO1998054312A1 Ribosome complexes as selection particles for in vitro display and evolution of proteins |
12/03/1998 | WO1998054311A1 Zinc finger protein derivatives and methods therefor |
12/03/1998 | WO1998054225A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes |
12/03/1998 | WO1998054213A2 Neurotrophic factor receptors |
12/03/1998 | WO1998054212A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor |
12/03/1998 | WO1998054206A1 32 human secreted proteins |
12/03/1998 | WO1998054202A1 Human tumor necrosis factor receptor tr10 |
12/03/1998 | WO1998053856A1 Methods for the detection, treatment, and prevention of neurodegeneration |
12/03/1998 | WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA |
12/03/1998 | WO1998045332A3 Humanized antibodies and methods for forming humanized antibodies |
12/03/1998 | WO1998045331A3 Anti-vegf antibodies |
12/03/1998 | WO1998040486A3 Secreted proteins and polynucleotides encoding them |
12/03/1998 | WO1998035027A3 Human nerve growth factor exon 1 and exon 3 promoters |
12/03/1998 | DE4244915C2 Fungal cells contg. mutated DPM2 mannosyl transferase gene |
12/03/1998 | DE19722888A1 Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten Human CD28 specific monoclonal antibodies for the antigen non-specific activation of T-lymphocytes |
12/03/1998 | CA2292790A1 Human tumor necrosis factor receptor tr10 |
12/03/1998 | CA2291960A1 Human type 3 ryanodine receptor protein and dna molecules coding therefor |
12/03/1998 | CA2291861A1 Zinc finger protein derivatives and methods therefor |
12/03/1998 | CA2291698A1 Osf2/cbfa1 compositions and methods of use |
12/03/1998 | CA2291512A1 Methods of making an rnp particle having nucleotide integrase activity |
12/03/1998 | CA2291323A1 Alternatively targeted adenovirus |
12/03/1998 | CA2291221A1 32 human secreted proteins |
12/03/1998 | CA2290954A1 Human multiple endocrine neoplasia type 1 protein |
12/03/1998 | CA2290943A1 New human dp1 homolog |
12/03/1998 | CA2288840A1 Integrin-targeting vectors having transfection activity |
12/03/1998 | CA2288235A1 Tumour suppressor gene dbccr1 at 9q32-33 |
12/02/1998 | EP0881299A1 Monoclonal antibody that recognizes antigens present on the surface of endothelial cell of tumor vessel |
12/02/1998 | EP0881298A2 Metalloporoteases |
12/02/1998 | EP0881294A2 HOEFCC11, a HAS2 splicing variant |
12/02/1998 | EP0881292A2 Streptocococcus pneumoniae peptide release factor |
12/02/1998 | EP0881289A2 Novel 7TM receptor (H2CAA71) |
12/02/1998 | EP0880701A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
12/02/1998 | EP0880597A1 THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 |
12/02/1998 | EP0880589A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
12/02/1998 | EP0880588A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
12/02/1998 | EP0880586A1 Lyst1 and lyst2 gene compositions and methods of use |
12/02/1998 | EP0880361A1 Immunogenic detoxified mutants of cholera toxin |
12/02/1998 | EP0771210A4 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ -g(g)1 CHAIN |
12/02/1998 | EP0724650A4 Selection and use of antiviral peptides |
12/02/1998 | EP0719265B1 Nucleoside derivatives, methods for the manufacture thereof and specific polyclonal and monoclonal antibodies of said derivatives |
12/02/1998 | EP0655162B1 Compositions of bacteriorhodopsin variants with increased memory time and their use |
12/02/1998 | EP0599913B1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same |
12/02/1998 | EP0527839B1 Recombinant library screening methods |
12/02/1998 | EP0527785B1 Improvements relating to the detection of viruses |
12/02/1998 | EP0515571B1 Hybrid reagents capable of selectively releasing molecules into cells |
12/02/1998 | CN1200763A New adhesion from helicobactor pylori |
12/02/1998 | CN1200737A Recombinant anti-CD4 antibodies for human therapy |